Table 5. Clinical data and age of death in homo- and hetero-FH patients in pre-statin and statin eras.

	M/F	Entry year	Entry age (yr)	TC (mg/dL) at entry	Death year	Death age (yr)
Homo-FH
Pre-statin (n = 7)	2/5	1976.6 ± 5.4	25.9 ± 11.1	706 ± 185	1979.0 ± 9.0	28.4 ± 12.7
Statin (n = 7)	4/3	1985.0 ± 6.5	42.9 ± 11.8	621 ± 112	2001.0 ± 7.0	58.7 ± 20.0
(Statin – Pre-statin)						+30.3 years P < 0.00001
Hetero-FH
Pre-statin (n = 108)	62/46	1980.2 ± 5.4	59.5 ± 12.6	357 ± 72	1984.1 ± 5.0	63.3 ± 12.3
Statin (n = 93)	51/42	1985.0 ± 7.4	57.4 ± 12.4	334 ± 59	2001.7 ± 6.9	75.9 ± 12.4
(Statin – Pre-statin)						+12.6 years P < 0.000000054

TC; total cholesterol (mg/dL), TG; triglyceride (mg/dL)

Data; mean ± SD